Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor gamma activated by macrophage-derived 12/15-lipoxygenase ligands.
about
The role of lipoxin A4 in endometrial biology and endometriosisPPARs and the cardiovascular systemPPAR and immune system--what do we know?PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationCholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone MiceInhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBPPeroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.A Role for PPARgamma in the Regulation of Cytokines in Immune Cells and Cancer.Construction of AAV-rat-IL4 and Evaluation of its Modulating Effect on Aβ (1-42)-Induced Proinflammatory Cytokines in Primary Microglia and the B92 Cell Line by Quantitative PCR AssayAgonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis.Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite InfectionHanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis.PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritisAngiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer.15-lipoxygenase-1 exerts its tumor suppressive role by inhibiting nuclear factor-kappa B via activation of PPAR gamma.
P2860
Q24564121-CDEB14AC-BA6A-4085-A031-DF429D0F21E3Q24642728-78CB15A7-85BE-4B66-95FF-C96248E3622EQ34913467-C630D148-0166-4E81-ACCA-5C773D171666Q35053566-0487FB63-ECE0-46F0-B592-5BB1428A2912Q36260399-390BDEDE-50CA-4A70-9FA3-F599399ADB32Q36447976-7D8BB235-E699-4D09-A795-4843E3510706Q36687379-31E84557-A159-4553-9532-296044F47D7EQ36724717-4C4B8812-ED70-4AC0-906C-6158D928F0CCQ36910522-4B4318D4-5BF5-4D7E-B447-B5BC5F301D63Q37211800-4A6F6FA8-5D51-4A76-819C-CD757B3A8ABAQ37451190-355F1FD0-4448-487B-8C1E-1544068F10ECQ37721788-28D30FA3-2342-4A24-AABD-B0A4DCB8820AQ38046124-47C44F73-8090-49F1-B88F-307E62136289Q38132128-74078D2F-F88F-41C4-9A69-4548074B1C81Q41830114-B925DAAA-169A-4996-8DA7-8C799324636DQ43601028-7E64A811-DC8F-448B-8A9F-D1A558EE25E4Q43917133-3DBBE55B-1BBF-4AAE-9478-F0167F8B14B8
P2860
Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor gamma activated by macrophage-derived 12/15-lipoxygenase ligands.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Interleukin (IL)-4 indirectly ...... ed 12/15-lipoxygenase ligands.
@en
type
label
Interleukin (IL)-4 indirectly ...... ed 12/15-lipoxygenase ligands.
@en
prefLabel
Interleukin (IL)-4 indirectly ...... ed 12/15-lipoxygenase ligands.
@en
P2093
P2860
P356
P1476
Interleukin (IL)-4 indirectly ...... ed 12/15-lipoxygenase ligands.
@en
P2093
Kelly Mihalic
Larry M Wahl
Li Hua Wang
Taosheng Chen
Weihua Xiao
William L Farrar
Xiao Yi Yang
P2860
P304
P356
10.1074/JBC.M105619200
P407
P577
2001-11-28T00:00:00Z